“High sensitivity versus low level of vancomycin needs to be concern for another alternative anti- Staphylococcus aureus as the first- line antibiotic” (2019) Acta Biomedica Atenei Parmensis, 90(4), pp. 498–503. doi:10.23750/abm.v90i4.7646.